Investor Biotechnology Value Fund L P
Manager Mark N. Lampert
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Biotechnology Value Fund L P . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-08-20 13G XFOR / X4 Pharmaceuticals, Inc. 2,258,400 2,243,659
2025-08-18 13G GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) 2,438,964 9,611,751
2025-08-14 13G/A VERV / Verve Therapeutics, Inc. 6,904,050 0
2025-08-14 13G/A VIGL / Vigil Neuroscience, Inc. 4,734,500 0
2025-08-14 13G/A UNCY / Unicycive Therapeutics, Inc. 1,417,117
2025-08-14 13G/A ITOS / iTeos Therapeutics, Inc. 3,075,000 0
2025-08-14 13G/A IMUX / Immunic, Inc. 8,902,972 9,785,178
2025-08-14 13G/A CBIO / Crescent Biopharma, Inc. 0 1,387,863
2025-08-13 13G/A VSTM / Verastem, Inc. 4,706,551 2,500,000
2025-08-13 13G/A VSTM / Verastem, Inc. 4,706,551 5,720,831
2025-08-07 13D/A EPIX / ESSA Pharma Inc. 8,748,629 11,668,473
2025-07-21 13G/A OVID / Ovid Therapeutics Inc. 3,853,818 0
2025-07-09 13G/A CTMX / CytomX Therapeutics, Inc. 8,089,795 5,769,231
2025-07-09 13G/A CTMX / CytomX Therapeutics, Inc. 8,089,795 11,538,462
2025-07-09 13G NKTR / Nektar Therapeutics 1,276,595
2025-06-16 13G PTGX / Protagonist Therapeutics, Inc. 2,970,427 3,211,041
2025-05-20 13D/A XOMA / XOMA Royalty Corporation 2,983,026 2,590,303
2025-05-19 13G/A ALLK / Allakos Inc. 16,552,417 0
2025-05-15 13G/A VIGL / Vigil Neuroscience, Inc. 2,739,727 4,734,500
2025-05-15 13G/A TCRX / TScan Therapeutics, Inc. 5,073,003 5,263,541
2025-05-15 13G/A SEPN / Septerna, Inc. 2,452,024 4,396,124
2025-05-15 13G/A ITOS / iTeos Therapeutics, Inc. 2,325,000 3,075,000
2025-05-15 13G/A GLUE / Monte Rosa Therapeutics, Inc. 4,393,210 5,660,132
2025-05-15 13G/A GHRS / GH Research PLC 10,400,158 8,827,712
2025-05-15 13G/A FDMT / 4D Molecular Therapeutics, Inc. 4,834,297 4,632,749
2025-05-15 13G/A ELEV / Elevation Oncology, Inc. 6,230,845 4,440,000
2025-05-15 13G/A CDTX / Cidara Therapeutics, Inc. 1,093,499 1,252,441
2025-05-09 13D/A IVA / Inventiva S.A. - Depositary Receipt (Common Stock) 8,545,499 8,545,499
2025-04-16 13G/A THRD / Third Harmonic Bio, Inc. 2,372,933 0
2025-04-09 13D EPIX / ESSA Pharma Inc. 8,748,629 8,748,629
2025-02-14 13G/A VTGN / Vistagen Therapeutics, Inc. 2,777,245 3,084,324
2025-02-14 13G/A VSTM / Verastem, Inc. 4,279,521 4,706,551
2025-02-14 13G/A TYRA / Tyra Biosciences, Inc. 4,661,194 3,944,194
2025-02-14 13G/A IKNA / Ikena Oncology, Inc. 4,769,164 4,006,564
2025-02-14 13G/A FDMT / 4D Molecular Therapeutics, Inc. 7,382,642 4,834,297
2025-02-14 13G/A FBRX / Forte Biosciences, Inc. 2,982,105 643,622
2025-02-14 13G/A ETNB / 89bio, Inc. 6,811,631 4,333,885
2025-02-14 13G/A CDTX / Cidara Therapeutics, Inc. 703,126 1,093,499
2025-02-14 13G/A AVTX / Avalo Therapeutics, Inc. 967,299 1,038,542
2025-02-04 13G KURA / Kura Oncology, Inc. 4,212,346 5,912,554
2025-02-04 13G/A KURA / Kura Oncology, Inc. 4,212,346 3,408,054
2025-01-31 13G GLUE / Monte Rosa Therapeutics, Inc. 4,393,210
2025-01-29 13G/A ENGN / enGene Holdings Inc. 3,196,439 945,402
2025-01-29 13G/A ENGN / enGene Holdings Inc. 3,196,439 3,051,439
2025-01-28 13D/A XOMA / XOMA Royalty Corporation 3,633,743 2,983,026
2025-01-06 13G RAPT / RAPT Therapeutics, Inc. 11,764,000
2024-12-23 13D/A IVA / Inventiva S.A. - Depositary Receipt (Common Stock) 8,545,499 8,545,499
2024-12-17 13G/A PVLA / Palvella Therapeutics, Inc. 1,168,117
2024-12-04 13D/A OLMA / Olema Pharmaceuticals, Inc. 9,135,893 7,557,237
2024-11-21 13G ITOS / iTeos Therapeutics, Inc. 1,259,476 2,325,000
2024-11-18 13G VERV / Verve Therapeutics, Inc. 6,904,050
2024-11-14 13G/A VSTM / Verastem, Inc. 2,617,402 4,279,521
2024-11-14 13G/A OVID / Ovid Therapeutics Inc. 6,851,051 3,853,818
2024-11-14 13G/A TCRX / TScan Therapeutics, Inc. 4,414,910 5,073,003
2024-11-14 13G/A ANNX / Annexon, Inc. 7,000,000 9,027,778
2024-11-14 13G/A MIRM / Mirum Pharmaceuticals, Inc. 4,370,024 3,075,907
2024-11-14 13G/A MTEM / Molecular Templates, Inc. 537,426 672,767
2024-11-14 13G/A ACIU / AC Immune SA 14,571,236 19,522,436
2024-11-14 13G/A VIRX / Viracta Therapeutics, Inc. 3,833,785 0
2024-11-14 13G/A TYRA / Tyra Biosciences, Inc. 2,739,595 4,661,194
2024-11-14 13G/A STRO / Sutro Biopharma, Inc. 3,347,946 0
2024-11-14 13G/A RGLS / Regulus Therapeutics Inc. 9,661,235 883,844
2024-11-14 13G/A KURA / Kura Oncology, Inc. 7,373,228 4,212,346
2024-11-14 13G/A ANTX / AN2 Therapeutics, Inc. 1,563,963 0
2024-11-14 13G/A ETNB / 89bio, Inc. 7,568,480 6,811,631
2024-11-14 13G/A PTGX / Protagonist Therapeutics, Inc. 5,763,948 2,970,427
2024-11-14 13G/A ELEV / Elevation Oncology, Inc. 4,450,885 6,230,845
2024-11-14 13G/A UNCY / Unicycive Therapeutics, Inc. 3,470,225 10,471,230
2024-11-14 13G/A LXRX / Lexicon Pharmaceuticals, Inc. 24,435,632 0
2024-11-14 13G/A CTMX / CytomX Therapeutics, Inc. 6,702,889 8,089,795
2024-11-14 13G/A ZYME / Zymeworks Inc. 5,870,000 4,607,935
2024-11-14 13G/A JANX / Janux Therapeutics, Inc. 4,579,818 0
2024-11-14 13G/A CGEM / Cullinan Therapeutics, Inc. 4,393,321 5,796,433
2024-11-14 13G/A CDTX / Cidara Therapeutics, Inc. 9,275,527 703,126
2024-11-14 13G/A IDYA / IDEAYA Biosciences, Inc. 3,479,043 1,409,993
2024-11-14 13G/A CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 8,774,570 0
2024-11-14 13G/A DCTH / Delcath Systems, Inc. 2,338,426 1,041,667
2024-11-13 13G/A FDMT / 4D Molecular Therapeutics, Inc. 4,007,413 7,382,642
2024-11-12 13G/A THRD / Third Harmonic Bio, Inc. 4,365,933 2,372,933
2024-11-01 13G SEPN / Septerna, Inc. 2,452,024
2024-10-31 13G/A ELDN / Eledon Pharmaceuticals, Inc. 4,326,710 6,293,282
2024-10-31 13G/A ELDN / Eledon Pharmaceuticals, Inc. 4,326,710 6,293,282
2024-10-29 13D/A MOLN / Molecular Partners AG - Depositary Receipt (Common Stock) 8,696,205 9,888,592
2024-10-21 13D/A IVA / Inventiva S.A. - Depositary Receipt (Common Stock) 8,545,499 8,545,499
2024-10-08 13D/A MLTX / MoonLake Immunotherapeutics 21,751,284 19,751,284
2024-09-11 13G/A CALT / Calliditas Therapeutics AB (publ) - Depositary Receipt (Common Stock) 6,260,311 0
2024-08-23 13G AVTX / Avalo Therapeutics, Inc. 967,299
2024-08-19 13G TENX / Tenax Therapeutics, Inc. 340,660
2024-07-19 13D/A IVA / Inventiva S.A. - Depositary Receipt (Common Stock) 8,545,499 8,545,499
2024-06-10 13G CELC / Celcuity Inc. 3,466,000
2024-05-30 13G FHTX / Foghorn Therapeutics Inc. 5,552,341
2024-05-17 13G PIRS / Pieris Pharmaceuticals, Inc. 20,609,863 257,622
2024-05-17 13G PIRS / Pieris Pharmaceuticals, Inc. 20,609,863 257,622
2024-03-05 13D/A MLTX / MoonLake Immunotherapeutics 21,751,284 21,751,284
2024-02-22 13G/A ENGN / enGene Holdings Inc. 3,196,439 3,196,439
2024-02-14 13G/A ACRS / Aclaris Therapeutics, Inc. 3,360,941 0
2024-02-14 13G/A RNTX / Rein Therapeutics Inc. 236,835 0
2024-02-14 13G/A ANNX / Annexon, Inc. 3,780,694 7,000,000
2024-02-14 13G/A ARAV / Aravive, Inc. 6,109,058 8,164,510
2024-02-14 13G/A ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock) 43,344,975
2024-02-14 13G/A BNOX / Bionomics Limited - Depositary Receipt (Common Stock) 170,089,885 0
2024-02-14 13G/A CDTX / Cidara Therapeutics, Inc. 6,861,127 9,275,527
2024-02-14 13G/A CGEM / Cullinan Therapeutics, Inc. 7,509,059 4,393,321
2024-02-14 13G/A CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 6,894,345 8,774,570
2024-02-14 13G/A CRNX / Crinetics Pharmaceuticals, Inc. 2,736,613 0
2024-02-14 13G/A CTMX / CytomX Therapeutics, Inc. 6,595,801 6,702,889
2024-02-14 13G/A ELDN / Eledon Pharmaceuticals, Inc. 2,326,710 4,326,710
2024-02-14 13G/A DCTH / Delcath Systems, Inc. 1,561,514 2,338,426
2024-02-14 13G/A ELEV / Elevation Oncology, Inc. 2,312,200 4,450,885
2024-02-14 13G/A ETNB / 89bio, Inc. 3,521,126 7,568,480
2024-02-14 13G/A FDMT / 4D Molecular Therapeutics, Inc. 4,007,413 4,007,413
2024-02-14 13G/A GHRS / GH Research PLC 9,275,158 10,400,158
2024-02-14 13G/A GLMD / Galmed Pharmaceuticals Ltd. 1,739,670 0
2024-02-14 13G/A IDYA / IDEAYA Biosciences, Inc. 2,455,089 3,479,043
2024-02-14 13G/A IKNA / Ikena Oncology, Inc. 2,503,071 4,769,164
2024-02-14 13G/A ITOS / iTeos Therapeutics, Inc. 1,810,835 1,259,476
2024-02-14 13G/A JANX / Janux Therapeutics, Inc. 4,106,945 4,579,818
2024-02-14 13G/A / JASPER THERAPEUTICS INC 9,900,000 0
2024-02-14 13G/A KURA / Kura Oncology, Inc. 3,800,983 7,373,228
2024-02-14 13G/A LXRX / Lexicon Pharmaceuticals, Inc. 16,149,179 24,435,632
2024-02-14 13G/A MRUS / Merus N.V. 2,978,420 2,752,420
2024-02-14 13G/A MTEM / Molecular Templates, Inc. 537,426
2024-02-14 13G/A PTGX / Protagonist Therapeutics, Inc. 5,025,900 5,763,948
2024-02-14 13G/A PYXS / Pyxis Oncology, Inc. 2,938,851 0
2024-02-14 13G/A RVMD / Revolution Medicines, Inc. 7,555,588 5,981,212
2024-02-14 13G/A TYRA / Tyra Biosciences, Inc. 2,472,327 2,739,595
2024-02-14 13G/A VRDN / Viridian Therapeutics, Inc. 2,302,094 0
2024-02-14 13G/A VSTM / Verastem, Inc. 2,617,402
2024-01-29 13D/A RAIN / Rain Enhancement Technologies Holdco, Inc. 3,526,729 0
2024-01-29 13G/A GLYC / GlycoMimetics, Inc. 9,544,262 9,544,262
2024-01-18 13G/A ALLK / Allakos Inc. 5,006,921 16,552,417
2024-01-18 13G/A ALLK / Allakos Inc. 5,006,921 8,552,417
2024-01-18 13G IMUX / Immunic, Inc. 8,902,972
2024-01-16 13D/A XOMA / XOMA Royalty Corporation 3,530,543 3,633,743
2024-01-09 13D/A KYMR / Kymera Therapeutics, Inc. 4,692,604 5,831,171
2023-12-20 13D/A PNT / POINT Biopharma Global Inc. 17,437,375 0
2023-12-20 13G/A GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) 12,660,518 2,438,964
2023-12-19 13G/A ACIU / AC Immune SA 7,428,379 14,571,236
2023-12-18 13D/A RAIN / Rain Enhancement Technologies Holdco, Inc. 3,526,729 3,526,729
2023-12-04 13G SABS / SAB Biotherapeutics, Inc. 9,178,282
2023-11-20 13D MOLN / Molecular Partners AG - Depositary Receipt (Common Stock) 6,492,517 8,696,205
2023-11-17 13D/A RPTX / Repare Therapeutics Inc. 9,098,600 10,333,600
2023-11-13 13G ENGN / enGene Holdings Inc. 3,196,439
2023-11-07 13G/A MOLN / Molecular Partners AG - Depositary Receipt (Common Stock) 4,510,072 6,492,517
2023-11-06 13D PNT / POINT Biopharma Global Inc. 9,177,748 17,437,375
2023-11-03 13D RPTX / Repare Therapeutics Inc. 8,291,988 9,098,600
2023-10-16 13G VTGN / Vistagen Therapeutics, Inc. 2,777,245
2023-09-25 13D/A IVA / Inventiva S.A. - Depositary Receipt (Common Stock) 8,545,499
2023-09-18 13G MIRM / Mirum Pharmaceuticals, Inc. 4,370,024
2023-09-14 13D/A OLMA / Olema Pharmaceuticals, Inc. 7,411,503 9,135,893
2023-08-17 13D/A RAIN / Rain Enhancement Technologies Holdco, Inc. 3,526,729 3,526,729
2023-08-17 13D/A PIRS / Pieris Pharmaceuticals, Inc. 20,609,863 20,609,863
2023-08-10 13G FBRX / Forte Biosciences, Inc. 0 2,982,105
2023-07-06 13G UNCY / Unicycive Therapeutics, Inc. 3,470,225
2023-06-30 13D/A MLTX / MoonLake Immunotherapeutics 21,751,284 21,751,284
2023-06-30 13G RVMD / Revolution Medicines, Inc. 1,810,549 7,555,588
2023-06-28 13D/A CTIC / CTI BioPharma Corp 28,463,021 0
2023-06-22 13G DCTH / Delcath Systems, Inc. 1,561,514
2023-06-05 13G TCRX / TScan Therapeutics, Inc. 4,414,910
2023-05-30 13G JANX / Janux Therapeutics, Inc. 4,106,945
2023-05-22 13D PIRS / Pieris Pharmaceuticals, Inc. 7,694,060 20,609,863
2023-03-24 13G IDYA / IDEAYA Biosciences, Inc. 2,205,089 2,455,089
2023-03-20 13G PTGX / Protagonist Therapeutics, Inc. 1,250,000 5,025,900
2023-03-16 13G ACRS / Aclaris Therapeutics, Inc. 3,276,543 3,360,941
2023-03-06 13G ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock) 42,440,000
2023-02-14 13G/A MOLN / Molecular Partners AG - Depositary Receipt (Common Stock) 4,526,282 4,510,072
2023-02-14 13G/A IDYA / IDEAYA Biosciences, Inc. 1,964,859 2,205,089
2023-02-14 13G/A GLMD / Galmed Pharmaceuticals Ltd. 1,799,694 1,739,670
2023-02-14 13G/A MRUS / Merus N.V. 4,135,071 2,978,420
2023-02-14 13G/A ETNB / 89bio, Inc. 3,898,000 3,521,126
2023-02-14 13G/A PNT / POINT Biopharma Global Inc. 5,590,048 9,177,748
2023-02-14 13G/A RCUS / Arcus Biosciences, Inc. 3,960,948 2,303,520
2023-02-14 13G/A CRNX / Crinetics Pharmaceuticals, Inc. 3,003,879 2,736,613
2023-02-14 13G/A RLMD / Relmada Therapeutics, Inc. 1,647,400 0
2023-02-14 13G/A COGT / Cogent Biosciences, Inc. 3,114,532 984,824
2023-02-14 13G/A SNDX / Syndax Pharmaceuticals, Inc. 4,931,879 1,451,197
2023-02-14 13G/A CGEM / Cullinan Therapeutics, Inc. 5,369,459 7,509,059
2023-02-14 13G/A CALT / Calliditas Therapeutics AB (publ) - Depositary Receipt (Common Stock) 6,260,311
2023-02-14 13G/A CALA / Calithera Biosciences, Inc. 488,367
2023-02-14 13G/A SPRO / Spero Therapeutics, Inc. 3,411,520 0
2023-02-14 13G/A STRO / Sutro Biopharma, Inc. 3,160,416 3,347,946
2023-02-14 13G/A ANTX / AN2 Therapeutics, Inc. 1,616,665 1,563,963
2023-02-14 13G/A RNTX / Rein Therapeutics Inc. 236,835
2023-02-14 13G/A VRDN / Viridian Therapeutics, Inc. 2,202,315 2,302,094
2023-02-14 13G/A ACRS / Aclaris Therapeutics, Inc. 3,868,043 3,276,543
2023-02-14 13G/A XENE / Xenon Pharmaceuticals Inc. 4,305,540 1,271,243
2023-02-14 13G/A XFOR / X4 Pharmaceuticals, Inc. 3,027,672 2,258,400
2023-02-14 13G/A VIRX / Viracta Therapeutics, Inc. 3,731,744 3,833,785
2023-02-14 13G/A ACIU / AC Immune SA 7,062,379 7,428,379
2023-02-14 13G/A RPTX / Repare Therapeutics Inc. 8,141,988 8,291,988
2023-02-14 13G/A ALPN / Alpine Immune Sciences, Inc. 1,589,495 1,353,815
2023-02-14 13G/A ANNX / Annexon, Inc. 3,343,194 3,780,694
2023-02-14 13G/A CNCE / Concert Pharmaceuticals Inc 3,596,757 4,917,774
2023-02-14 13G/A ELEV / Elevation Oncology, Inc. 1,611,698 2,312,200
2023-02-14 13G/A EYRYY / Erytech Pharma 2,299,301 517,242
2023-02-14 13G/A IKNA / Ikena Oncology, Inc. 1,798,371 2,503,071
2023-02-14 13G/A PYXS / Pyxis Oncology, Inc. 1,791,351 2,938,851
2023-02-14 13G/A ITOS / iTeos Therapeutics, Inc. 1,929,201 1,810,835
2023-02-14 13G/A KURA / Kura Oncology, Inc. 3,547,083 3,800,983
2023-02-14 13G/A PTGX / Protagonist Therapeutics, Inc. 4,891,945 1,250,000
2023-02-14 13G/A LXRX / Lexicon Pharmaceuticals, Inc. 14,360,000 16,149,179
2023-02-14 13G/A OVID / Ovid Therapeutics Inc. 6,631,051 6,851,051
2023-02-14 13G/A MTEM / Molecular Templates, Inc. 3,379,599 5,246,565
2023-02-14 13G/A PIRS / Pieris Pharmaceuticals, Inc. 7,406,643 7,694,060
2023-02-14 13G/A VSTM / Verastem, Inc. 18,506,158 20,094,466
2023-02-13 13G GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) 12,660,518
2023-02-06 13G / JASPER THERAPEUTICS INC 9,900,000
2023-01-03 13G ZYME / Zymeworks Inc. 5,870,000
2022-12-23 13G/A EYRYY / Erytech Pharma 5,119,183 2,299,301
2022-12-21 13G/A THRD / Third Harmonic Bio, Inc. 3,501,814 4,365,933
2022-12-16 13G NLSP / NLS Pharmaceutics AG 6,859,146
2022-12-05 13G KURA / Kura Oncology, Inc. 1,245,912 3,547,083
2022-11-10 13D/A RAIN / Rain Enhancement Technologies Holdco, Inc. 3,526,729 3,526,729
2022-11-07 13G ARAV / Aravive, Inc. 6,109,058
2022-09-29 13G ALLK / Allakos Inc. 5,006,921
2022-09-26 13G THRD / Third Harmonic Bio, Inc. 3,501,814
2022-09-26 13G PNT / POINT Biopharma Global Inc. 2,920,526 5,590,048
2022-08-26 13G VIGL / Vigil Neuroscience, Inc. 2,739,727
2022-08-23 13D/A KYMR / Kymera Therapeutics, Inc. 4,138,758 4,692,604
2022-08-11 13D/A CTIC / CTI BioPharma Corp 17,123,023 28,463,021
2022-07-29 13G/A CTMX / CytomX Therapeutics, Inc. 5,803,700 6,595,801
2022-07-19 13G/A CFRX / ContraFect Corp 3,972,300 1,847,299
2022-07-12 13G/A EPIX / ESSA Pharma Inc. 4,565,242 8,748,629
2022-07-11 13G ETNB / 89bio, Inc. 3,898,000
2022-06-21 13G/A FDMT / 4D Molecular Therapeutics, Inc. 2,005,862 4,007,413
2022-06-16 13G CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 6,894,345
2022-06-06 13G/A RPTX / Repare Therapeutics Inc. 4,858,761 8,141,988
2022-06-01 13D/A KYMR / Kymera Therapeutics, Inc. 3,586,658 4,138,758
2022-05-26 13G ANNX / Annexon, Inc. 3,343,194
2022-05-02 13G ITOS / iTeos Therapeutics, Inc. 1,929,201
2022-05-02 13G IDYA / IDEAYA Biosciences, Inc. 559 1,964,859
2022-04-18 13D MLTX / MoonLake Immunotherapeutics 21,751,284
2022-04-04 13G / AN2 THERAPEUTICS 1,616,665
2022-03-24 13G TYRA / Tyra Biosciences, Inc. 2,472,327
2022-03-21 13G/A XENE / Xenon Pharmaceuticals Inc. 5,157,486 4,305,540
2022-03-14 13G RCUS / Arcus Biosciences, Inc. 2,752,222 3,960,948
2022-02-14 13G/A INFI / Infinity Pharmaceuticals Inc. 8,383,645 6,353,645
2022-02-14 13G/A PIRS / Pieris Pharmaceuticals, Inc. 5,601,582 7,406,643
2022-02-14 13G/A XENE / Xenon Pharmaceuticals Inc. 3,499,346 5,157,486
2022-02-14 13G/A VRDN / Viridian Therapeutics, Inc. 7,584,219 2,202,315
2022-02-14 13G/A EYRYY / Erytech Pharma 4,081,941 5,119,183
2022-02-14 13G ELEV / Elevation Oncology, Inc. 1,611,698
2022-02-14 13G/A EPIX / ESSA Pharma Inc. 3,705,289 4,565,242
2022-02-14 13G/A ACIU / AC Immune SA 7,916,658 7,062,379
2022-02-14 13G COGT / Cogent Biosciences, Inc. 3,114,250 3,114,532
2022-02-14 13G/A IKNA / Ikena Oncology, Inc. 1,599,658 1,798,371
2022-02-14 13G/A VIRX / Viracta Therapeutics, Inc. 1,814,308 3,731,744
2022-02-14 13G/A MTEM / Molecular Templates, Inc. 2,761,121 3,379,599
2022-02-14 13G/A SPRO / Spero Therapeutics, Inc. 2,768,278 3,411,520
2022-02-14 13G/A CGEM / Cullinan Therapeutics, Inc. 4,394,459 5,369,459
2022-02-14 13G/A SELB / Selecta Biosciences Inc 4,926,108 1,723,133
2022-02-14 13G/A ALPN / Alpine Immune Sciences, Inc. 1,137,764 1,589,495
2022-02-14 13G/A SNDX / Syndax Pharmaceuticals, Inc. 3,710,689 4,931,879
2022-02-14 13G/A RGLS / Regulus Therapeutics Inc. 7,050,464 9,661,235
2022-02-14 13G/A XFOR / X4 Pharmaceuticals, Inc. 1,719,616 3,027,672
2022-02-14 13G/A FWP / Forward Pharma A/S - ADR 10,194,786 7,193,088
2022-02-14 13G BNOX / Bionomics Limited - Depositary Receipt (Common Stock) 170,089,885
2022-02-14 13G GHRS / GH Research PLC 9,275,158
2022-02-14 13G/A IDYA / IDEAYA Biosciences, Inc. 1,787,559 559
2022-02-14 13G/A MRUS / Merus N.V. 5,060,071 4,135,071
2022-02-14 13G/A PNT / POINT Biopharma Global Inc. 2,920,526 2,920,526
2022-02-14 13G/A RVMD / Revolution Medicines, Inc. 3,757,049 1,810,549
2022-02-14 13G/A AADI / Aadi Bioscience, Inc. 1,147,052 899,392
2022-02-14 13G/A FBRX / Forte Biosciences, Inc. 1,344,262 0
2022-02-14 13G/A CRVS / Corvus Pharmaceuticals, Inc. 2,898,797 1,370,947
2022-02-14 13G/A GRTS / Gritstone bio, Inc. 2,695,418 0
2022-02-14 13G/A GNCA / Genocea Biosciences Inc 5,285,549 5,930,353
2022-02-14 13G/A LXRX / Lexicon Pharmaceuticals, Inc. 10,963,000 14,360,000
2022-02-14 13G/A PTGX / Protagonist Therapeutics, Inc. 4,274,965 4,891,945
2022-02-14 13G/A RPTX / Repare Therapeutics Inc. 3,722,398 4,858,761
2022-01-31 13D/A KYMR / Kymera Therapeutics, Inc. 2,630,662 3,586,658
2022-01-28 13G/A ELDN / Eledon Pharmaceuticals, Inc. 1,448,020 2,326,710
2022-01-24 13G ACRS / Aclaris Therapeutics, Inc. 3,868,043
2022-01-18 13G STRO / Sutro Biopharma, Inc. 1,854,162 3,160,416
2022-01-12 13G/A MOLN / Molecular Partners AG - Depositary Receipt (Common Stock) 2,498,901 4,526,282
2022-01-12 13G/A MOLN / Molecular Partners AG - Depositary Receipt (Common Stock) 2,498,901 3,101,282
2022-01-11 13D/A RAIN / Rain Enhancement Technologies Holdco, Inc. 2,945,807 3,526,729
2022-01-11 13G/A ELDN / Eledon Pharmaceuticals, Inc. 195,326 1,448,020
2022-01-11 13G/A ELDN / Eledon Pharmaceuticals, Inc. 195,326 1,434,932
2022-01-10 13G/A VSTM / Verastem, Inc. 11,180,994 18,506,158
2022-01-10 13G/A VSTM / Verastem, Inc. 11,180,994 17,062,158
2022-01-03 13G CTMX / CytomX Therapeutics, Inc. 2,919,471 5,803,700
2021-12-20 13G RLMD / Relmada Therapeutics, Inc. 1,647,400
2021-12-20 13G/A CGEM / Cullinan Therapeutics, Inc. 2,606,806 4,394,459
2021-12-20 13G PYXS / Pyxis Oncology, Inc. 1,791,351
2021-12-16 13G/A CDTX / Cidara Therapeutics, Inc. 4,461,494 6,861,127
2021-12-02 13D/A OLMA / Olema Pharmaceuticals, Inc. 6,661,503 7,411,503
2021-11-15 13G CNCE / Concert Pharmaceuticals Inc 0 3,596,757
2021-11-08 13G CGEM / Cullinan Therapeutics, Inc. 2,606,806
2021-10-29 13G CRNX / Crinetics Pharmaceuticals, Inc. 3,003,879
2021-09-15 13G MOLN / Molecular Partners AG - Depositary Receipt (Common Stock) 2,498,901
2021-09-15 13D/A RAIN / Rain Enhancement Technologies Holdco, Inc. 2,545,253 2,945,807
2021-09-07 13G AADI / Aadi Bioscience, Inc. 1,147,052
2021-07-08 13G/A CALA / Calithera Biosciences, Inc. 4,361,238 7,452,331
2021-07-07 13G/A MRUS / Merus N.V. 5,805,571 5,060,071
2021-07-06 13D/A RAIN / Rain Enhancement Technologies Holdco, Inc. 1,945,949 2,545,253
2021-07-06 13G FDMT / 4D Molecular Therapeutics, Inc. 2,005,862
2021-05-25 13D/A RAIN / Rain Enhancement Technologies Holdco, Inc. 1,852,511 1,945,949
2021-05-17 13G RVMD / Revolution Medicines, Inc. 3,757,049
2021-05-03 13G/A CTMX / CytomX Therapeutics, Inc. 5,576,471 2,919,471
2021-04-29 13G/A IDYA / IDEAYA Biosciences, Inc. 3,226,769 1,787,559
2021-04-28 13D RAIN / Rain Enhancement Technologies Holdco, Inc. 1,852,511
2021-04-15 13G/A OVID / Ovid Therapeutics Inc. 4,522,051 6,631,051
2021-04-15 13G/A CFRX / ContraFect Corp 2,908,913 3,972,300
2021-04-05 13G IKNA / Ikena Oncology, Inc. 1,599,658
2021-04-02 13D/A XOMA / XOMA Royalty Corporation 4,182,243 3,530,543
2021-03-16 13G/A RPTX / Repare Therapeutics Inc. 2,972,191 3,722,398
2021-03-15 13D/A CTIC / CTI BioPharma Corp 12,753,690 17,123,023
2021-03-10 13G EYRYY / Erytech Pharma 4,081,941 4,081,941
2021-03-08 13G/A US33830X1046 / Five Prime Therapeutics Inc 3,138,678 6,338,678
2021-03-05 13G FVAM / 5:01 Acquisition Corp. 500,000
2021-02-19 13G INFI / Infinity Pharmaceuticals Inc. 8,383,645 8,383,645
2021-02-16 13G/A 867328601 / Sunesis Pharmaceuticals, Inc. 1,814,308 1,814,308
2021-02-16 13G/A XENE / Xenon Pharmaceuticals Inc. 3,499,346 3,499,346
2021-02-16 13G/A RGLS / Regulus Therapeutics Inc. 2,096,708 7,050,464
2021-02-16 13G/A / Therapeutics Acquisition Corp. Class A 1,000,000 954,996
2021-02-16 13G/A SPRO / Spero Therapeutics, Inc. 2,028,405 2,768,278
2021-02-16 13G/A FSTX / F-star Therapeutics Inc 25,844 25,844
2021-02-16 13G/A XFOR / X4 Pharmaceuticals, Inc. 1,719,616 1,719,616
2021-02-16 13G/A PTGX / Protagonist Therapeutics, Inc. 4,274,965 4,274,965
2021-02-16 13D/A INFI / Infinity Pharmaceuticals Inc. 10,726,968 8,383,645
2021-02-16 13G/A 88907J107 / Novus Therapeutics, Inc. 1,518,039 1,503,121
2021-02-16 13G/A 867328601 / Sunesis Pharmaceuticals, Inc. 3,895,026 1,814,308
2021-02-16 13G/A RGLS / Regulus Therapeutics Inc. 7,050,464 7,050,464
2021-02-16 13G/A SPRO / Spero Therapeutics, Inc. 2,768,278 2,768,278
2021-02-16 13G/A FSTX / F-star Therapeutics Inc 951,701 25,844
2021-02-16 13G/A XENE / Xenon Pharmaceuticals Inc. 3,516,851 3,499,346
2021-02-16 13G/A / Therapeutics Acquisition Corp. Class A 954,996 954,996
2021-02-16 13G/A XFOR / X4 Pharmaceuticals, Inc. 1,660,475 1,719,616
2021-02-16 13G/A PTGX / Protagonist Therapeutics, Inc. 2,332,630 4,274,965
2021-02-12 13G/A SNDX / Syndax Pharmaceuticals, Inc. 2,816,390 3,710,689
2021-02-12 13G/A GNCA / Genocea Biosciences Inc 3,161,668 5,285,549
2021-02-12 13G/A STRO / Sutro Biopharma, Inc. 2,368,392 1,854,162
2021-02-12 13G/A PIRS / Pieris Pharmaceuticals, Inc. 5,872,762 5,601,582
2021-02-12 13G/A RPTX / Repare Therapeutics Inc. 1,944,546 2,972,191
2021-02-12 13G/A OVID / Ovid Therapeutics Inc. 5,255,301 4,522,051
2021-02-12 13G/A MRUS / Merus N.V. 4,990,571 5,805,571
2021-02-12 13G/A KZR / Kezar Life Sciences, Inc. 2,039,788 0
2021-02-12 13G/A GLMD / Galmed Pharmaceuticals Ltd. 1,832,484 1,799,694
2021-02-12 13G/A FBRX / Forte Biosciences, Inc. 1,089,983 1,344,262
2021-02-12 13G/A CRVS / Corvus Pharmaceuticals, Inc. 2,921,177 2,898,797
2021-02-12 13G/A CDTX / Cidara Therapeutics, Inc. 3,368,758 4,461,494
2021-02-11 13G/A MEIP / MEI Pharma, Inc. 6,886,425 5,589,315
2021-02-11 13G/A CTMX / CytomX Therapeutics, Inc. 4,626,411 5,576,471
2021-02-11 13G/A CALA / Calithera Biosciences, Inc. 7,090,638 4,361,238
2021-02-11 13G/A MTEM / Molecular Templates, Inc. 3,608,332 2,761,121
2021-02-11 13G/A EPIX / ESSA Pharma Inc. 2,640,565 3,705,289
2021-02-11 13G/A FWP / Forward Pharma A/S - ADR 14,092,736 10,194,786
2021-02-11 13G/A SWTX / SpringWorks Therapeutics, Inc. 3,079,155
2021-02-11 13G/A GLYC / GlycoMimetics, Inc. 7,361,801 9,544,262
2021-02-11 13G/A REPL / Replimune Group, Inc. 2,309,109 0
2021-02-11 13G/A SURF / Surface Oncology Inc 2,125,650 0
2021-02-11 13G/A MRSN / Mersana Therapeutics, Inc. 3,755,553 0
2021-02-11 13G/A IDYA / IDEAYA Biosciences, Inc. 3,224,172 3,226,769
2021-02-11 13G/A KURA / Kura Oncology, Inc. 2,434,696 1,245,912
2021-02-11 13G/A COGT / Cogent Biosciences, Inc. 4,154,000 3,114,250
2021-02-11 13G/A CRIS / Curis, Inc. 3,650,000 626,945
2021-02-11 13G/A ANAB / AnaptysBio, Inc. 1,441,565 0
2021-02-11 13G/A CLDX / Celldex Therapeutics, Inc. 2,740,000 0
2021-02-11 13G/A BBI / Brickell Biotech Inc 664,079 0
2021-02-11 13G/A VSTM / Verastem, Inc. 6,328,994 11,180,994
2021-02-01 13G US33830X1046 / Five Prime Therapeutics Inc 1,263,678 3,138,678
2021-01-29 13D/A EYRYY / Erytech Pharma 4,461,941 4,081,941
2021-01-26 13D/A INFI / Infinity Pharmaceuticals Inc. 17,426,968 10,726,968
2021-01-19 13G ALRN / Rein Therapeutics Inc. 5,265,555
2021-01-14 13G/A ACIU / AC Immune SA 11,342,505 7,916,658
2021-01-13 13G/A CYTK / Cytokinetics, Incorporated 7,358,019 2,728,035
2021-01-12 13D/A EYRYY / Erytech Pharma 4,461,941 4,461,941
2021-01-11 13G GRTS / Gritstone bio, Inc. 2,695,418
2020-12-30 13G/A 88907J107 / Novus Therapeutics, Inc. 1,514,519 1,518,039
2020-12-28 13G/A 88907J107 / Novus Therapeutics, Inc. 195,326 1,514,519
2020-12-21 13G LXRX / Lexicon Pharmaceuticals, Inc. 10,963,000
2020-12-15 13D/A XOMA / XOMA Royalty Corporation 4,182,243 4,182,243
2020-12-10 13G/A RCUS / Arcus Biosciences, Inc. 3,579,023 2,752,222
2020-11-20 13D OLMA / Olema Pharmaceuticals, Inc. 6,661,503
2020-11-16 13G/A CYTK / Cytokinetics, Incorporated 3,938,280 7,358,019
2020-11-13 13D/A US33830X1046 / Five Prime Therapeutics Inc 8,364,353 1,263,678
2020-11-12 13D/A INFI / Infinity Pharmaceuticals Inc. 17,426,968 17,426,968
2020-11-12 13G/A CALT / Calliditas Therapeutics AB (publ) - Depositary Receipt (Common Stock) 7,431,562
2020-11-10 13G/A CTMX / CytomX Therapeutics, Inc. 3,188,948 4,626,411
2020-11-09 13G VRDN / Viridian Therapeutics, Inc. 7,584,219
2020-11-03 13G/A BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock) 31,242,465 5,946,840
2020-10-20 13G CFRX / ContraFect Corp 2,773,989 2,908,913
2020-10-13 13D/A EYRYY / Erytech Pharma 4,547,662 4,461,941
2020-10-09 13D/A XOMA / XOMA Royalty Corporation 4,182,243 4,182,243
2020-10-08 13D/A US33830X1046 / Five Prime Therapeutics Inc 7,783,001 8,364,353
2020-10-05 13G/A ELDN / Eledon Pharmaceuticals, Inc. 1,336,556 195,326
2020-09-23 13D/A XOMA / XOMA Royalty Corporation 1,503,565 4,182,243
2020-08-25 13D KYMR / Kymera Therapeutics, Inc. 2,630,662
2020-08-25 13D US74257L1089 / Principia Biopharma Inc. 5,231,900 5,231,900
2020-08-19 13G US74257L1089 / Principia Biopharma Inc. 1,716,734 5,231,900
2020-07-20 13G / Therapeutics Acquisition Corp. Class A 1,000,000
2020-07-16 13G COGT / Cogent Biosciences, Inc. 4,154,000
2020-06-30 13G RPTX / Repare Therapeutics Inc. 1,944,546 1,944,546
2020-06-29 13G RPTX / Repare Therapeutics Inc. 1,944,546
2020-06-26 13G CLDX / Celldex Therapeutics, Inc. 2,740,000
2020-06-25 13G FBRX / Forte Biosciences, Inc. 1,089,983
2020-06-22 13G CRIS / Curis, Inc. 3,650,000
2020-06-22 13G/A XENE / Xenon Pharmaceuticals Inc. 2,656,057 3,516,851
2020-06-22 13G/A IDYA / IDEAYA Biosciences, Inc. 1,436,429 3,224,172
2020-06-03 13G/A MRUS / Merus N.V. 3,169,654 4,990,571
2020-06-02 13G/A BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock) 31,242,465 31,242,465
2020-06-01 13G/A BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock) 31,942,380 31,242,465
2020-05-29 13G SURF / Surface Oncology Inc 2,125,650
2020-05-26 13G/A CALA / Calithera Biosciences, Inc. 9,559,642 7,090,638
2020-05-22 13G STRO / Sutro Biopharma, Inc. 2,368,392
2020-04-01 13G/A CYTK / Cytokinetics, Incorporated 7,206,458 3,938,280
2020-03-16 13G KURA / Kura Oncology, Inc. 1,998,276 2,434,696
2020-03-06 13G CTMX / CytomX Therapeutics, Inc. 1,124,483 3,188,948
2020-03-04 13D/A CTIC / CTI BioPharma Corp 12,753,690 12,753,690
2020-02-19 13G/A PIRS / Pieris Pharmaceuticals, Inc. 5,506,905 5,872,762
2020-02-18 13G/A SPRO / Spero Therapeutics, Inc. 2,028,405 2,028,405
2020-02-18 13G/A CRVS / Corvus Pharmaceuticals, Inc. 3,082,997 2,921,177
2020-02-15 13G/A SPRO / Spero Therapeutics, Inc. 2,028,405
2020-02-14 13G/A ALPN / Alpine Immune Sciences, Inc. 1,201,718 1,137,764
2020-02-14 13G/A CDTX / Cidara Therapeutics, Inc. 2,904,684 3,368,758
2020-02-14 13G/A CRVS / Corvus Pharmaceuticals, Inc. 3,032,850 3,082,997
2020-02-14 13G/A BBI / Brickell Biotech Inc 664,079
2020-02-14 13G/A FWP / Forward Pharma A/S - ADR 18,092,758 14,092,736
2020-02-14 13G/A RCUS / Arcus Biosciences, Inc. 2,411,623 3,579,023
2020-02-14 13G/A CYTK / Cytokinetics, Incorporated 4,150,639 7,206,458
2020-02-14 13G/A MRUS / Merus N.V. 3,343,413 3,169,654
2020-02-14 13G/A SWTX / SpringWorks Therapeutics, Inc. 3,079,155
2020-02-14 13G/A ACIU / AC Immune SA 11,297,911 11,342,505
2020-02-14 13G/A CCXI / ChemoCentryx Inc 6,687,523 0
2020-02-14 13G/A GLYC / GlycoMimetics, Inc. 7,361,801 7,361,801
2020-02-14 13G/A CNCE / Concert Pharmaceuticals Inc 1,408,187 0
2020-02-14 13G/A VSTM / Verastem, Inc. 5,512,994 6,328,994
2020-02-14 13G/A MACK / Merrimack Pharmaceuticals, Inc. 721,935 0
2020-02-14 13G/A GLMD / Galmed Pharmaceuticals Ltd. 1,878,508 1,832,484
2020-02-14 13G/A VBIV / VBI Vaccines Inc. 5,216,857 0
2020-02-14 13G/A MTEM / Molecular Templates, Inc. 3,364,421 3,608,332
2020-02-14 13G/A FSTX / F-star Therapeutics Inc 951,701 951,701
2020-02-14 13G/A US74257L1089 / Principia Biopharma Inc. 1,636,850 1,716,734
2020-02-14 13G/A XENE / Xenon Pharmaceuticals Inc. 2,602,836 2,656,057
2020-02-14 13G/A 867328601 / Sunesis Pharmaceuticals, Inc. 3,895,026 11,653,925
2020-02-14 13G BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock) 31,942,477 31,942,380
2020-02-14 13G/A GNCA / Genocea Biosciences Inc 7,614,455 3,161,668
2020-02-14 13G/A ARQL / ArQule, Inc. 8,670,350 4,902,383
2020-02-14 13G/A XFOR / X4 Pharmaceuticals, Inc. 1,292,416 1,660,475
2020-02-14 13G/A SNDX / Syndax Pharmaceuticals, Inc. 2,535,878 2,816,390
2020-02-14 13G/A RGLS / Regulus Therapeutics Inc. 1,051,940 2,096,708
2020-02-14 13G/A PIRS / Pieris Pharmaceuticals, Inc. 7,457,921 5,506,905
2020-02-14 13G/A OVID / Ovid Therapeutics Inc. 3,772,000 5,255,301
2020-02-14 13G/A KURA / Kura Oncology, Inc. 2,775,156 1,998,276
2020-02-14 13G/A MEIP / MEI Pharma, Inc. 4,518,861 6,886,425
2020-02-14 13G/A PTGX / Protagonist Therapeutics, Inc. 2,502,390 2,332,630
2020-02-14 13G/A REPL / Replimune Group, Inc. 1,606,817 2,309,109
2020-02-14 13G/A EPIX / ESSA Pharma Inc. 1,329,700 2,640,565
2020-02-14 13G/A MRSN / Mersana Therapeutics, Inc. 4,926,419 3,755,553
2020-02-14 13G/A IDYA / IDEAYA Biosciences, Inc. 1,505,429 1,436,429
2020-02-14 13G/A CALA / Calithera Biosciences, Inc. 6,750,482 9,559,642
2020-02-10 13G KZR / Kezar Life Sciences, Inc. 2,039,788
2020-02-04 13D/A CTIC / CTI BioPharma Corp 12,753,896 12,753,690
2020-02-04 13G ANAB / AnaptysBio, Inc. 594,397 1,441,565
2020-01-10 13D/A INFI / Infinity Pharmaceuticals Inc. 17,151,968 17,426,968
2020-01-07 13G SELB / Selecta Biosciences Inc 4,926,108
2019-12-27 13D US33830X1046 / Five Prime Therapeutics Inc 7,783,001 7,783,001
2019-12-26 13D US33830X1046 / Five Prime Therapeutics Inc 5,967,119 7,783,001
2019-11-12 13G/A MRUS / Merus N.V. 4,514,913 3,343,413
2019-11-08 13G/A US33830X1046 / Five Prime Therapeutics Inc 4,143,891 5,967,119
2019-10-28 13G US74257L1089 / Principia Biopharma Inc. 1,636,850
2019-10-09 13G/A MRSN / Mersana Therapeutics, Inc. 2,500,000 4,926,419
2019-10-02 13G/A US33830X1046 / Five Prime Therapeutics Inc 2,781,346 4,143,891
2019-09-23 13G SWTX / SpringWorks Therapeutics, Inc. 2,843,845
2019-09-16 13G/A ACIU / AC Immune SA 7,455,534 11,297,911
2019-09-09 13G/A GLYC / GlycoMimetics, Inc. 4,436,801 7,361,801
2019-08-15 13G GLYC / GlycoMimetics, Inc. 497,474 4,436,801
2019-08-07 13G/A CRVS / Corvus Pharmaceuticals, Inc. 1,890,507 3,032,850
2019-07-03 13G/A CNCE / Concert Pharmaceuticals Inc 2,785,487 1,408,187
2019-06-28 13G/A EPIX / ESSA Pharma Inc. 1,329,700 1,329,700
2019-06-27 13G/A EPIX / ESSA Pharma Inc. 580,367 1,329,700
2019-06-25 13G/A CALA / Calithera Biosciences, Inc. 3,298,282 6,750,482
2019-06-07 13G IDYA / IDEAYA Biosciences, Inc. 1,505,429
2019-05-20 13G VSTM / Verastem, Inc. 3,513,994 5,512,994
2019-05-10 13G 88907J107 / Novus Therapeutics, Inc. 1,336,556
2019-04-26 13D/A OMED / OptMed Inc 4,042,989 0
2019-04-23 13G XFOR / X4 Pharmaceuticals, Inc. 1,292,416
2019-04-08 13G BBI / Brickell Biotech Inc 2,279,059 2,279,059
2019-04-02 13G/A CNCE / Concert Pharmaceuticals Inc 1,381,845 2,785,487
2019-03-26 13G REPL / Replimune Group, Inc. 1,606,817
2019-03-21 13G/A ACIU / AC Immune SA 5,663,760 7,455,534
2019-03-19 13D/A BBI / Brickell Biotech Inc 2,278,598 2,279,059
2019-03-15 13D OMED / OptMed Inc 4,042,989 4,042,989
2019-03-11 13G MRSN / Mersana Therapeutics, Inc. 2,500,000
2019-03-04 13G OVID / Ovid Therapeutics Inc. 3,772,000
2019-03-01 13D/A BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock) 26,026,200 31,942,477
2019-02-25 13G/A IMDZ / Immune Design Corp. 5,185,383 0
2019-02-14 13G/A SPRO / Spero Therapeutics, Inc. 1,815,146
2019-02-14 13G/A ONCT / Oncternal Therapeutics, Inc. 0
2019-02-14 13G/A CYTK / Cytokinetics, Incorporated 5,515,256 4,150,639
2019-02-14 13G/A RGLS / Regulus Therapeutics Inc. 13,974,249 1,051,940
2019-02-14 13G/A VIRX / Viracta Therapeutics, Inc. 3,570,362 3,895,026
2019-02-14 13G/A OREX / Orexigen Therapeutics, Inc. 1,534,050 2,036,860
2019-02-14 13G/A RLM / Realm Therapeutics plc 177,738,291 21,451,171
2019-02-14 13G/A PTGX / Protagonist Therapeutics, Inc. 2,617,967 2,502,390
2019-02-14 13G/A XENE / Xenon Pharmaceuticals Inc. 1,492,836 2,602,836
2019-02-14 13G/A SNDX / Syndax Pharmaceuticals, Inc. 3,233,618 2,535,878
2019-02-14 13G/A MTEM / Molecular Templates, Inc. 2,787,629 3,364,421
2019-02-14 13G/A CRVS / Corvus Pharmaceuticals, Inc. 1,954,254 1,890,507
2019-02-14 13G/A IMDZ / Immune Design Corp. 5,231,353 5,185,383
2019-02-14 13G/A MRUS / Merus N.V. 3,914,913 4,514,913
2019-02-14 13G/A CCXI / ChemoCentryx Inc 7,587,416 6,687,523
2019-02-14 13G/A US33830X1046 / Five Prime Therapeutics Inc 3,599,317 2,781,346
2019-02-14 13G/A MACK / Merrimack Pharmaceuticals, Inc. 1,112,300 721,935
2019-02-14 13G/A CALA / Calithera Biosciences, Inc. 2,019,000 3,298,282
2019-02-14 13G/A VSTM / Verastem, Inc. 2,737,000 3,513,994
2019-02-14 13G/A OMED / OptMed Inc 4,271,289 4,042,989
2019-02-14 13G/A GLMD / Galmed Pharmaceuticals Ltd. 1,048,076 1,878,508
2019-02-14 13G/A CFRX / ContraFect Corp 5,250,000 2,773,989
2019-02-14 13G/A ARQL / ArQule, Inc. 12,076,844 8,670,350
2019-02-14 13G/A GNCA / Genocea Biosciences Inc 7,500,000 7,614,455
2019-02-14 13G/A RCUS / Arcus Biosciences, Inc. 2,421,440 2,411,623
2019-02-14 13G/A KURA / Kura Oncology, Inc. 2,057,346 2,775,156
2019-02-14 13G/A MEIP / MEI Pharma, Inc. 4,620,462 4,518,861
2019-02-14 13G/A FSTX / F-star Therapeutics Inc 823,474 951,701
2019-02-14 13G/A FWP / Forward Pharma A/S - ADR 181,716,681 18,092,758
2019-02-14 13G/A GTXOD / Metalert Inc 0
2019-02-14 13G/A PIRS / Pieris Pharmaceuticals, Inc. 5,626,295 7,457,921
2019-02-12 13G ACIU / AC Immune SA 5,663,760 5,663,760
2019-02-11 13G ACIU / AC Immune SA 5,663,760
2019-02-07 13G/A CNCE / Concert Pharmaceuticals Inc 1,969,789 1,150,445
2019-02-07 13G CNCE / Concert Pharmaceuticals Inc 1,969,789 1,381,845
2019-02-01 13G/A BBI / Brickell Biotech Inc 1,907,875 2,278,598
2019-02-01 13D BBI / Brickell Biotech Inc 1,907,875 2,278,598
2019-01-28 13G ALPN / Alpine Immune Sciences, Inc. 1,201,718
2019-01-10 13G/A CYTK / Cytokinetics, Incorporated 5,721,888 5,515,256
2018-12-28 13G/A CDTX / Cidara Therapeutics, Inc. 2,904,684 2,904,684
2018-12-27 13G/A CDTX / Cidara Therapeutics, Inc. 2,846,430 2,904,684
2018-12-26 13G VBIV / VBI Vaccines Inc. 5,216,857
2018-11-26 13G RCUS / Arcus Biosciences, Inc. 2,421,440
2018-11-21 13D/A INFI / Infinity Pharmaceuticals Inc. 15,232,268 17,151,968
2018-11-08 13D/A EYRYY / Erytech Pharma 36,306,621 4,547,662
2018-10-17 13G/A IMDZ / Immune Design Corp. 5,231,353 5,231,353
2018-10-17 13G/A EPIX / ESSA Pharma Inc. 10,000,000 580,367
2018-10-16 13G/A IMDZ / Immune Design Corp. 4,106,200 5,231,353
2018-10-04 13G/A US33830X1046 / Five Prime Therapeutics Inc 2,155,324 3,599,317
2018-10-01 13G MTEM / Molecular Templates, Inc. 2,787,629
2018-09-04 13G CALA / Calithera Biosciences, Inc. 2,019,000
2018-09-04 13G US33830X1046 / Five Prime Therapeutics Inc 2,155,324
2018-08-10 13G/A PTGX / Protagonist Therapeutics, Inc. 1,467,967 2,617,967
2018-07-19 13D EYRYY / Erytech Pharma 34,372,271 3,630,662
2018-07-19 13G RLM / Realm Therapeutics plc 17,773,829
2018-07-12 13G/A PIRS / Pieris Pharmaceuticals, Inc. 4,679,562 5,626,295
2018-07-09 13G KURA / Kura Oncology, Inc. 2,057,346
2018-07-02 13G/A EYRYY / Erytech Pharma 9,301,751 3,437,227
2018-06-21 13D/A INFI / Infinity Pharmaceuticals Inc. 11,276,508 15,232,268
2018-06-19 13G/A MRUS / Merus N.V. 2,419,443 3,914,913
2018-06-04 13G CDTX / Cidara Therapeutics, Inc. 2,846,430
2018-06-01 13G/A ARQL / ArQule, Inc. 17,553,089 12,076,844
2018-05-29 13G MEIP / MEI Pharma, Inc. 4,620,462
2018-05-24 13G PTGX / Protagonist Therapeutics, Inc. 1,467,967
2018-05-04 13G/A FWP / Forward Pharma A/S - ADR 106,428,341 18,171,668
2018-04-16 13G GLMD / Galmed Pharmaceuticals Ltd. 1,048,076
2018-04-12 13D INFI / Infinity Pharmaceuticals Inc. 9,766,508 11,276,508
2018-04-10 13G MACK / Merrimack Pharmaceuticals, Inc. 1,112,300
2018-03-29 13G/A XENE / Xenon Pharmaceuticals Inc. 3,588,830 1,492,836
2018-03-19 13G CRVS / Corvus Pharmaceuticals, Inc. 1,954,254
2018-03-05 13G/A MRUS / Merus N.V. 2,124,443 2,419,443
2018-02-23 13G MRUS / Merus N.V. 2,124,443
2018-02-14 13G/A ONCT / Oncternal Therapeutics, Inc. 2,218,514
2018-02-14 13G/A PIRS / Pieris Pharmaceuticals, Inc. 4,573,142 4,679,562
2018-02-14 13G/A XENE / Xenon Pharmaceuticals Inc. 3,043,805 3,588,830
2018-02-14 13G/A FSTX / F-star Therapeutics Inc 652,676 823,474
2018-02-14 13G/A RGLS / Regulus Therapeutics Inc. 12,949,229 13,974,249
2018-02-14 13G/A CTMX / CytomX Therapeutics, Inc. 2,026,998 1,124,483
2018-02-14 13G/A FATE / Fate Therapeutics, Inc. 3,759,398 0
2018-02-14 13G/A FBRX / Forte Biosciences, Inc. 556,683
2018-02-14 13G/A SNDX / Syndax Pharmaceuticals, Inc. 2,547,318 3,233,618
2018-02-14 13G/A ANAB / AnaptysBio, Inc. 1,904,600 594,397
2018-02-14 13G/A CNCE / Concert Pharmaceuticals Inc 2,616,249 1,969,789
2018-02-14 13G/A CCXI / ChemoCentryx Inc 7,798,572 7,587,416
2018-02-14 13G/A ANTH / Anthera Pharmaceuticals, Inc. 4,649,588 1,658,157
2018-02-14 13G/A OMED / OptMed Inc 3,961,689 4,271,289
2018-02-14 13G/A GLYC / GlycoMimetics, Inc. 2,454,786 497,474
2018-02-14 13G/A INFI / Infinity Pharmaceuticals Inc. 7,860,808 9,766,508
2018-02-14 13G/A CYTK / Cytokinetics, Incorporated 5,427,313 5,721,888
2018-02-14 13G/A VIRX / Viracta Therapeutics, Inc. 2,160,295 3,570,362
2018-02-12 13D/A CTIC / CTI BioPharma Corp 8,596,357 12,753,896
2018-02-09 13G/A IMDZ / Immune Design Corp. 1,320,164 1,469,800
2018-02-09 13G IMDZ / Immune Design Corp. 1,320,164 4,106,200
2018-01-29 13G GNCA / Genocea Biosciences Inc 7,500,000
2018-01-26 13G VSTM / Verastem, Inc. 2,737,000
2018-01-16 13G EPIX / ESSA Pharma Inc. 10,000,000
2018-01-03 13G FWP / Forward Pharma A/S - ADR 106,428,341 10,642,834
2018-01-02 13G FWP / Forward Pharma A/S - ADR 106,428,341
2018-01-02 13G EYRYY / Erytech Pharma 930,175
2017-12-13 13G/A GLYC / GlycoMimetics, Inc. 2,826,282 2,454,786
2017-11-30 13G/A CYTK / Cytokinetics, Incorporated 3,266,321 5,427,313
2017-11-17 13G/A SNDX / Syndax Pharmaceuticals, Inc. 2,021,018 2,547,318
2017-11-17 13G BBI / Brickell Biotech Inc 1,907,875
2017-11-14 13G SNDX / Syndax Pharmaceuticals, Inc. 2,021,018
2017-11-09 13G SPRO / Spero Therapeutics, Inc. 1,029,185
2017-10-20 13G/A ARQL / ArQule, Inc. 17,553,114 17,553,089
2017-10-16 13G/A ARQL / ArQule, Inc. 7,867,966 17,553,114
2017-08-11 13G FSTX / F-star Therapeutics Inc 652,676
2017-08-08 13D BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock) 17,500,000 26,026,200
2017-07-28 13G CFRX / ContraFect Corp 5,250,000
2017-07-27 13G/A ALPN / Alpine Immune Sciences, Inc. 661,200
2017-07-27 13G/A ALPN / Alpine Immune Sciences, Inc. 1,864,474 661,200
2017-07-24 13G/A RGLS / Regulus Therapeutics Inc. 3,278,900 12,949,229
2017-07-18 13G/A CAPS / Capstone Holding Corp. 7,755,688 2,714,491
2017-06-30 13G CTMX / CytomX Therapeutics, Inc. 2,026,998 2,026,998
2017-06-29 13G CTMX / CytomX Therapeutics, Inc. 2,026,998
2017-06-14 13D/A CTIC / CTI BioPharma Corp 8,596,357
2017-06-14 13D/A CTIC / CTI BioPharma Corp 15,592,160 8,596,357
2017-05-31 13G/A OMED / OptMed Inc 1,843,484 3,961,689
2017-05-30 13G/A OMED / OptMed Inc 2,985,489 1,843,484
2017-05-15 13G/A CYTK / Cytokinetics, Incorporated 4,851,691 3,266,321
2017-05-05 13G RGLS / Regulus Therapeutics Inc. 3,278,900
2017-05-03 13G/A BPMC / Blueprint Medicines Corporation 3,255,280 1,928,546
2017-04-27 13G OMED / OptMed Inc 1,812,005 2,985,489
2017-04-21 13G FBRX / Forte Biosciences, Inc. 1,750,000
2017-04-10 13G BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock) 17,500,000
2017-02-21 13D XOMA / XOMA Royalty Corporation 302,800 1,503,565
2017-02-14 13G/A ONCT / Oncternal Therapeutics, Inc. 1,643,899
2017-02-14 13G/A ALPN / Alpine Immune Sciences, Inc. 1,864,474
2017-02-14 13G/A BPMC / Blueprint Medicines Corporation 2,840,251 3,255,280
2017-02-14 13G/A GLYC / GlycoMimetics, Inc. 2,447,415 2,826,282
2017-02-14 13G/A IMDZ / Immune Design Corp. 1,339,792 1,320,164
2017-02-14 13G/A CCXI / ChemoCentryx Inc 7,229,952 7,798,572
2017-02-14 13G/A CNCE / Concert Pharmaceuticals Inc 2,232,014 2,616,249
2017-02-14 13G/A ALPN / Alpine Immune Sciences, Inc. 1,546,743 1,864,474
2017-02-14 13G/A / Array BioPharma, Inc. 7,850,211 4,986,186
2017-02-14 13G/A VIRX / Viracta Therapeutics, Inc. 8,902,230 2,160,295
2017-02-14 13G/A VTAE / Vitae Pharmaceuticals, Inc. 2,061,325 0
2017-02-14 13G/A XENE / Xenon Pharmaceuticals Inc. 3,108,905 3,043,805
2017-02-14 13G/A CYTK / Cytokinetics, Incorporated 3,908,329 4,851,691
2017-02-14 13G/A CBIO / Crescent Biopharma, Inc. 1,161,234 0
2017-02-14 13G/A ANTH / Anthera Pharmaceuticals, Inc. 4,582,033 4,649,588
2017-02-14 13G/A ARQL / ArQule, Inc. 6,809,843 7,867,966
2017-02-14 13G/A PIRS / Pieris Pharmaceuticals, Inc. 4,778,999 4,573,142
2017-02-14 13G/A GTXI / GTx, Inc. 1,643,899
2017-02-03 13G ANAB / AnaptysBio, Inc. 1,904,600
2017-02-02 13D/A CASC / Cascadian Therapeutics, Inc. 4,851,595 6,008,224
2017-02-02 13G CASC / Cascadian Therapeutics, Inc. 4,851,595 6,008,224
2017-02-02 13D/A ONTY / Oncothyreon, Inc. 4,851,595 6,008,224
2017-02-02 13G ONTY / Oncothyreon, Inc. 6,008,224 6,008,224
2017-01-17 13D/A CASC / Cascadian Therapeutics, Inc. 27,773,238 4,851,595
2017-01-17 13D/A ONTY / Oncothyreon, Inc. 27,773,238 4,851,595
2016-12-30 13G/A INFI / Infinity Pharmaceuticals Inc. 5,050,000 7,860,808
2016-12-01 13G FATE / Fate Therapeutics, Inc. 3,759,398
2016-11-18 13G XOMA / XOMA Royalty Corporation 302,800
2016-11-14 13G IMDZ / Immune Design Corp. 1,339,792
2016-09-22 13G/A TBRA / Tobira Therapeutics, Inc. 2,136,204 399,433
2016-09-16 13G ANTH / Anthera Pharmaceuticals, Inc. 4,582,033
2016-09-12 13G/A XENE / Xenon Pharmaceuticals Inc. 1,775,572 3,108,905
2016-09-01 13G/A TBRA / Tobira Therapeutics, Inc. 1,253,401 2,136,204
2016-08-26 13G OMED / OptMed Inc 1,812,005
2016-07-19 13G OREX / Orexigen Therapeutics, Inc. 1,534,050
2016-07-05 13G/A NVLN / NOVELION THERAPEUTICS INC. 5,364,385 2,255,476
2016-06-27 13D/A CASC / Cascadian Therapeutics, Inc. 18,799,368 27,773,238
2016-06-27 13G GLYC / GlycoMimetics, Inc. 2,447,415
2016-06-24 13G INFI / Infinity Pharmaceuticals Inc. 5,050,000
2016-06-17 13G PIRS / Pieris Pharmaceuticals, Inc. 4,778,999
2016-05-03 13G/A BPMC / Blueprint Medicines Corporation 2,278,459 2,840,251
2016-03-22 13G/A ALPN / Alpine Immune Sciences, Inc. 1,546,743
2016-03-22 13G/A ALPN / Alpine Immune Sciences, Inc. 1,195,013 1,546,743
2016-03-18 13G/A XENE / Xenon Pharmaceuticals Inc. 1,125,572 1,775,572
2016-03-03 13G/A CYTK / Cytokinetics, Incorporated 3,841,680 3,908,329
2016-02-16 13G/A ONCT / Oncternal Therapeutics, Inc. 14,348,640
2016-02-16 13G/A XENE / Xenon Pharmaceuticals Inc. 821,264 1,125,572
2016-02-16 13G/A LOXO / Loxo Oncology, Inc. 711,067
2016-02-16 13G/A BPMC / Blueprint Medicines Corporation 1,695,408 2,278,459
2016-02-16 13G/A PTN / Palatin Technologies, Inc. 3,400,000
2016-02-16 13G/A SPHS / Sophiris Bio Inc 0
2016-02-16 13G/A CAPS / Capstone Holding Corp. 7,755,688
2016-02-16 13G/A ACHV / Achieve Life Sciences, Inc. 431,035
2016-02-16 13G/A CNCE / Concert Pharmaceuticals Inc 2,390,408 2,232,014
2016-02-16 13G/A TBRA / Tobira Therapeutics, Inc. 1,253,401
2016-02-16 13G/A AOLS / Aeolus Pharmaceuticals, Inc. 15,213,480
2016-02-16 13G/A GBIM / GlobeImmune, Inc. 678,400 657,653
2016-02-16 13G/A VTAE / Vitae Pharmaceuticals, Inc. 2,375,933 2,061,325
2016-02-16 13G/A CBIO / Crescent Biopharma, Inc. 1,156,480 1,161,234
2016-02-16 13G/A CYTK / Cytokinetics, Incorporated 3,841,680
2016-02-16 13G/A VIRX / Viracta Therapeutics, Inc. 8,902,230
2016-02-16 13G/A ARQL / ArQule, Inc. 6,356,118 6,809,843
2016-02-05 13G/A CCXI / ChemoCentryx Inc 4,832,263 7,229,952
2016-02-05 13G/A / Array BioPharma, Inc. 7,850,211
2016-01-14 13D/A TRGT / Targacept 44,796,940
2016-01-14 13D/A CTIC / CTI BioPharma Corp 15,592,160 44,796,940
2016-01-12 13D/A CASC / Cascadian Therapeutics, Inc. 18,799,368 18,799,368
2016-01-11 13D/A TRGT / Targacept 44,796,940
2016-01-11 13D/A CTIC / CTI BioPharma Corp 44,796,940
2016-01-11 13D/A CASC / Cascadian Therapeutics, Inc. 18,799,368 18,799,368
2015-12-31 13G/A NVLN / NOVELION THERAPEUTICS INC. 5,364,385
2015-12-21 13G ALPN / Alpine Immune Sciences, Inc. 1,195,013
2015-12-21 13G ALPN / Alpine Immune Sciences, Inc. 1,195,013
2015-12-21 13D CASC / Cascadian Therapeutics, Inc. 14,588,796 18,799,368
2015-12-11 13D TRGT / Targacept
2015-12-11 13D CTIC / CTI BioPharma Corp 14,897,559
2015-12-07 13G/A CTIC / CTI BioPharma Corp 10,000,000 43,795,613
2015-11-09 13G/A CCXI / ChemoCentryx Inc 4,832,263
2015-10-02 13G CTIC / CTI BioPharma Corp 10,000,000
2015-09-30 13G/A VTAE / Vitae Pharmaceuticals, Inc. 2,375,933
2015-08-21 13D/A CBIO / Crescent Biopharma, Inc. 7,020,128 1,156,480
2015-08-21 13G CBIO / Crescent Biopharma, Inc. 7,020,128 1,156,480
2015-08-18 13G/A CASC / Cascadian Therapeutics, Inc. 9,561,363 14,588,796
2015-08-07 13D/A TRGT / Targacept 7,020,128
2015-08-07 13D/A CBIO / Crescent Biopharma, Inc. 6,655,128 7,020,128
2015-07-10 13G XENE / Xenon Pharmaceuticals Inc. 821,264
2015-06-05 13G GBIM / GlobeImmune, Inc. 678,400
2015-05-28 13G/A ARQL / ArQule, Inc. 6,356,118
2015-05-28 13G/A CNCE / Concert Pharmaceuticals Inc 2,390,408
2015-05-18 13G/A CASC / Cascadian Therapeutics, Inc. 9,561,363
2015-05-15 13D/A TRGT / Targacept 6,655,128
2015-05-15 13D/A CBIO / Crescent Biopharma, Inc. 6,655,128
2015-05-08 13G BPMC / Blueprint Medicines Corporation 1,695,408
2015-03-18 13D/A TRGT / Targacept 6,655,128
2015-03-18 13D/A CBIO / Crescent Biopharma, Inc. 6,655,128
2015-02-17 13G/A PTN / Palatin Technologies, Inc. 3,400,000
2015-02-17 13G/A LGND / Ligand Pharmaceuticals Incorporated 860,063
2015-02-17 13G VTAE / Vitae Pharmaceuticals, Inc. 1,530,935
2015-02-17 13G/A VTAE / Vitae Pharmaceuticals, Inc. 753,935
2015-02-17 13G/A US33830X1046 / Five Prime Therapeutics Inc 826,332
2015-02-17 13G/A IRWD / Ironwood Pharmaceuticals, Inc. 5,093,810
2015-02-17 13G/A XENE / Xenon Pharmaceuticals Inc. 618,224
2015-02-17 13G/A LOXO / Loxo Oncology, Inc. 1,190,702
2015-02-17 13G/A CCXI / ChemoCentryx Inc 8,596,772
2015-02-17 13G/A RCPT / Receptos, Inc. 0
2015-02-17 13G/A AOLS / Aeolus Pharmaceuticals, Inc. 14,046,821
2015-02-17 13G/A VIRX / Viracta Therapeutics, Inc. 3,136,000
2015-02-17 13G/A CYTK / Cytokinetics, Incorporated 3,364,152
2015-02-17 13G/A CAPS / Capstone Holding Corp. 7,755,688
2015-02-17 13G/A TBRA / Tobira Therapeutics, Inc. 1,882,521
2015-02-17 13G/A CASC / Cascadian Therapeutics, Inc. 13,762,260
2015-02-17 13G/A ARQL / ArQule, Inc. 4,723,811
2015-02-17 13G/A / Array BioPharma, Inc. 11,772,335
2015-02-10 13D TRGT / Targacept 6,655,128
2015-01-08 13G NVLN / NOVELION THERAPEUTICS INC. 2,650,563
2014-12-24 13G SPHS / Sophiris Bio Inc 1,060,283
2014-12-12 13G ACHV / Achieve Life Sciences, Inc. 1,368,500
2014-11-24 13G GTXO / GTX Corp 11,111,111
2014-11-14 13G XENE / Xenon Pharmaceuticals Inc. 703,724
2014-11-14 13G VIRX / Viracta Therapeutics, Inc. 3,166,000
2014-10-23 13G VTAE / Vitae Pharmaceuticals, Inc. 900,935
2014-09-15 13G/A PTN / Palatin Technologies, Inc. 4,150,655
2014-09-12 13G CNCE / Concert Pharmaceuticals Inc 1,206,459
2014-09-05 13D TRGT / Targacept 6,655,128
2014-08-22 13G RCPT / Receptos, Inc. 1,434,600
2014-08-21 13G/A LGND / Ligand Pharmaceuticals Incorporated 1,408,599
2014-08-15 13G ARQL / ArQule, Inc. 4,300,887
2014-08-11 13G LOXO / Loxo Oncology, Inc. 1,205,000
2014-06-27 13G/A / Array BioPharma, Inc. 14,715,786
2014-05-09 13G CYTK / Cytokinetics, Incorporated 2,238,052
2014-03-25 13G/A CYTK / Cytokinetics, Incorporated 1,796,557
2014-03-25 13G/A TBRA / Tobira Therapeutics, Inc. 2,330,393
2014-03-12 13G/A RIGL / Rigel Pharmaceuticals, Inc. 2,576,707
2014-02-14 13G/A RGLS / Regulus Therapeutics Inc. 233,689
2014-02-14 13G/A CASC / Cascadian Therapeutics, Inc. 14,001,778
2014-02-14 13G/A RIGL / Rigel Pharmaceuticals, Inc. 7,943,215
2014-02-14 13G/A / Array BioPharma, Inc. 7,553,089
2014-02-14 13G/A CCXI / ChemoCentryx Inc 7,796,516
2014-02-14 13G/A NVLN / NOVELION THERAPEUTICS INC. 2,370,263
2014-02-14 13G/A SAVA / Cassava Sciences, Inc. 0
2014-02-14 13G/A HRTX / Heron Therapeutics, Inc. 2,880,817
2014-02-14 13G/A CYTK / Cytokinetics, Incorporated 3,289,957
2014-02-14 13G/A IRWD / Ironwood Pharmaceuticals, Inc. 9,575,649
2014-02-14 13G/A AOLS / Aeolus Pharmaceuticals, Inc. 17,147,178
2014-02-14 13G US33830X1046 / Five Prime Therapeutics Inc 1,136,000
2014-02-14 13G/A GNVC / GenVec, Inc. 0
2014-02-04 13G/A TBRA / Tobira Therapeutics, Inc. 3,659,091
2013-12-06 13G/A LGND / Ligand Pharmaceuticals Incorporated 2,626,160
2013-08-23 13G TBRA / Tobira Therapeutics, Inc. 1,750,000
2013-06-07 13G/A CASC / Cascadian Therapeutics, Inc. 8,093,278
2013-05-15 13G/A RIGL / Rigel Pharmaceuticals, Inc. 9,697,997
2013-03-01 13G AOLS / Aeolus Pharmaceuticals, Inc. 17,440,552
2013-02-15 13G CASC / Cascadian Therapeutics, Inc. 2,885,914
2013-02-14 13G/A NBIX / Neurocrine Biosciences, Inc. 0
2013-02-14 13G/A CYTK / Cytokinetics, Incorporated 15,839,746
2013-02-14 13G/A NKTR / Nektar Therapeutics 2,734,724
2013-02-14 13G/A INFI / Infinity Pharmaceuticals Inc. 0
2013-02-14 13G/A CCXI / ChemoCentryx Inc 5,026,766
2013-02-14 13G/A NVLN / NOVELION THERAPEUTICS INC. 4,372,000
2013-02-14 13G/A RGLS / Regulus Therapeutics Inc. 2,718,200
2013-02-14 13G/A SAVA / Cassava Sciences, Inc. 3,257,327
2013-02-14 13G/A MYRX / Myrexis, Inc. 1,673,486
2013-02-14 13G/A IRWD / Ironwood Pharmaceuticals, Inc. 5,287,127
2013-02-14 13G/A LGND / Ligand Pharmaceuticals Incorporated 3,582,065
2013-02-14 13G/A RIGL / Rigel Pharmaceuticals, Inc. 7,867,997
2013-02-14 13G/A TRGT / Targacept 6,171,669
2013-02-14 13G/A ECYT / Endocyte, Inc. 1,639,000
2013-02-14 13G/A AVDL / Avadel Pharmaceuticals plc 216,581
2013-02-14 13G/A GNVC / GenVec, Inc. 1,116,600
2012-11-19 13G/A / Array BioPharma, Inc. 11,431,858
2012-11-16 13G/A TRGT / Targacept 5,430,869
2012-11-05 13G IRWD / Ironwood Pharmaceuticals, Inc. 4,117,827
2012-10-15 13G RGLS / Regulus Therapeutics Inc. 3,000,000
2012-09-10 13G/A TRGT / Targacept 3,662,740
2012-08-31 13G/A CCXI / ChemoCentryx Inc 4,986,766
2012-07-16 13G NVLN / NOVELION THERAPEUTICS INC. 4,173,500
2012-07-03 13G CYTK / Cytokinetics, Incorporated 13,771,847
2012-06-18 13G ECYT / Endocyte, Inc. 1,879,300
2012-05-29 13G CCXI / ChemoCentryx Inc 2,250,899
2012-05-15 13G/A TRGT / Targacept 1,746,940
2012-04-20 13G SAVA / Cassava Sciences, Inc. 2,555,827
2012-02-10 13G/A / Array BioPharma, Inc. 8,223,469
2012-02-10 13G/A RIGL / Rigel Pharmaceuticals, Inc. 6,964,590
2012-02-10 13G/A INFI / Infinity Pharmaceuticals Inc. 2,184,908
2012-02-10 13G/A RGEN / Repligen Corporation 0
2012-02-10 13G/A NKTR / Nektar Therapeutics 7,639,000
2012-02-10 13G/A HRTX / Heron Therapeutics, Inc. 19,950,001
2012-02-10 13G/A TRGT / Targacept 3,267,602
2012-02-10 13G/A NBIX / Neurocrine Biosciences, Inc. 5,928,865
2012-02-10 13G/A ASTX / Investment Managers Series Trust II - Tradr 2X Long ASTS Daily ETF 0
2012-02-10 13G/A GNVC / GenVec, Inc. 1,194,100
2000-02-01 13G/A IMGN / ImmunoGen, Inc. 1,507,547
1999-10-14 13G IMGN / ImmunoGen, Inc. 3,764,705